Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Role of Global Longitudinal Strain in the Prediction of Outcome in Patients With Severe Aortic Valve Stenosis.

Fries B, Liu D, Gaudron P, Hu K, Nordbeck P, Ertl G, Weidemann F, Herrmann S.

Am J Cardiol. 2017 Aug 15;120(4):640-647. doi: 10.1016/j.amjcard.2017.05.032. Epub 2017 May 30.

PMID:
28648391
2.

The septal bulge--an early echocardiographic sign in hypertensive heart disease.

Gaudron PD, Liu D, Scholz F, Hu K, Florescu C, Herrmann S, Bijnens B, Ertl G, Störk S, Weidemann F.

J Am Soc Hypertens. 2016 Jan;10(1):70-80. doi: 10.1016/j.jash.2015.11.006. Epub 2015 Dec 2.

3.

Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis.

Hu K, Liu D, Nordbeck P, Cikes M, Störk S, Kramer B, Gaudron PD, Schneider A, Knop S, Ertl G, Bijnens B, Weidemann F, Herrmann S.

Int J Cardiovasc Imaging. 2015 Oct;31(7):1401-12. doi: 10.1007/s10554-015-0711-1. Epub 2015 Jul 16.

PMID:
26179863
4.

Long term evolution of magnetic resonance imaging characteristics in a case of atypical left lateral wall hypertrophic cardiomyopathy.

Gassenmaier T, Petritsch B, Kunz AS, Gkaniatsas S, Gaudron PD, Weidemann F, Nordbeck P, Beer M.

World J Cardiol. 2015 Jun 26;7(6):357-60. doi: 10.4330/wjc.v7.i6.357.

5.

Predictive value of assessing diastolic strain rate on survival in cardiac amyloidosis patients with preserved ejection fraction.

Liu D, Hu K, Störk S, Herrmann S, Kramer B, Cikes M, Gaudron PD, Knop S, Ertl G, Bijnens B, Weidemann F.

PLoS One. 2014 Dec 26;9(12):e115910. doi: 10.1371/journal.pone.0115910. eCollection 2014.

6.

Atypical hypertrophic cardiomyopathy of the left lateral wall leading to ventricular tachycardia.

Gkaniatsas S, Gaudron PD, Gassenmaier T, Beer M, Weidemann F, Nordbeck P.

Eur Heart J. 2014 Mar;35(9):548. doi: 10.1093/eurheartj/eht412. Epub 2013 Oct 16. No abstract available.

PMID:
24132188
7.

Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy.

Liu D, Hu K, Niemann M, Herrmann S, Cikes M, Störk S, Gaudron PD, Knop S, Ertl G, Bijnens B, Weidemann F.

Circ Cardiovasc Imaging. 2013 Nov;6(6):1066-72. doi: 10.1161/CIRCIMAGING.113.000683. Epub 2013 Oct 7.

8.

[Assessment of systolic function in patients with poor echogenicity: echocardiographic methods].

Weidemann F, Liu D, Niemann M, Herrmann S, Hu H, Gaudron PD, Ertl G, Hu K.

Herz. 2015 Apr;40(2):240-9. doi: 10.1007/s00059-013-3924-x. Epub 2013 Aug 15. Review. German.

PMID:
23942734
9.

Impact of regional left ventricular function on outcome for patients with AL amyloidosis.

Liu D, Hu K, Niemann M, Herrmann S, Cikes M, Störk S, Beer M, Gaudron PD, Morbach C, Knop S, Geissinger E, Ertl G, Bijnens B, Weidemann F.

PLoS One. 2013;8(3):e56923. doi: 10.1371/journal.pone.0056923. Epub 2013 Mar 8.

10.

Methods for assessment of left ventricular systolic function in technically difficult patients with poor imaging quality.

Hu K, Liu D, Niemann M, Herrmann S, Gaudron PD, Ertl G, Weidemann F.

J Am Soc Echocardiogr. 2013 Feb;26(2):105-13. doi: 10.1016/j.echo.2012.11.004. Epub 2012 Dec 17. Review.

PMID:
23257213
11.

Clinical implication of mitral annular plane systolic excursion for patients with cardiovascular disease.

Hu K, Liu D, Herrmann S, Niemann M, Gaudron PD, Voelker W, Ertl G, Bijnens B, Weidemann F.

Eur Heart J Cardiovasc Imaging. 2013 Mar;14(3):205-12. doi: 10.1093/ehjci/jes240. Epub 2012 Nov 15. Review.

PMID:
23161791
12.

Differentiation between fresh and old left ventricular thrombi by deformation imaging.

Niemann M, Gaudron PD, Bijnens B, Störk S, Beer M, Hillenbrand H, Cikes M, Herrmann S, Hu K, Ertl G, Weidemann F.

Circ Cardiovasc Imaging. 2012 Sep 1;5(5):667-75. Epub 2012 Jul 5.

13.

Echocardiographic quantification of regional deformation helps to distinguish isolated left ventricular non-compaction from dilated cardiomyopathy.

Niemann M, Liu D, Hu K, Cikes M, Beer M, Herrmann S, Gaudron PD, Hillenbrand H, Voelker W, Ertl G, Weidemann F.

Eur J Heart Fail. 2012 Feb;14(2):155-61. doi: 10.1093/eurjhf/hfr164. Epub 2012 Jan 4.

14.

The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes.

Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, Fox KA, Goldberg RJ, Anderson FA Jr; Expanded Global Registry of Acute Coronary Events (GRACE2) Investigators.

Am Heart J. 2009 Aug;158(2):193-201.e1-5. doi: 10.1016/j.ahj.2009.06.003.

PMID:
19619694
15.

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.

Brugts JJ, de Maat MP, Boersma E, Witteman JC, van Duijn C, Uitterlinden AG, Bertrand M, Remme W, Fox K, Ferrari R, Danser AH, Simoons ML; EUROPA-PERGENE investigators.

Cardiovasc Drugs Ther. 2009 Apr;23(2):171-81. doi: 10.1007/s10557-008-6156-1. Epub 2008 Dec 10.

PMID:
19082699
16.

[Treatment of the acute coronary syndrome in Germany: experiences in a German cluster of the GRACE registry].

Tebbe U, Bramlage P, von Löwis of Menar P, Lawall H, Gaudron P, Lüders S, Klaus A, Lengfelder W, Scholz KH, Maziejewski S, Cuneo A, Hohmann V, Gulba D.

Dtsch Med Wochenschr. 2007 Sep;132(39):2000-5. German.

PMID:
17882737
17.

Myocardial contractile efficiency increases in proportion to a fetal enzyme shift in chronically infarcted rat hearts.

Naumann A, Neubauer S, Kuhlencordt P, Hu K, Tian R, Gaudron P, Ertl G.

Basic Res Cardiol. 2005 Mar;100(2):171-8. Epub 2005 Feb 3.

PMID:
15685398
19.

Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.

Hu K, Naumann A, Fraccarollo D, Gaudron P, Kaden JJ, Neubauer S, Ertl G.

Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1281-8.

20.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators.

N Engl J Med. 2003 Nov 13;349(20):1893-906. Epub 2003 Nov 10. Erratum in: N Engl J Med. 2004 Jan 8;350(2):203.

Supplemental Content

Loading ...
Support Center